'Standard therapies' presentation slideshows

Activity Goals

Activity Goals. Incidence of Basal Cell Carcinoma (BCC). Standard Therapies: Non-Melanoma Skin Cancer (NMSC). Risk Factors. Risk Factors (cont). Prognosis. Demographics. Mohs Micrographic Surgery (MMS) a. The MMS Procedure Description and Illustration. Therapies for BCC.

441 views • 34 slides

Practical Considerations in Clinical Management

426 views • 24 slides

Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov

Management of the Patient with Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function. Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov. Case Overview. Patient is a 55-year old male with a history of stable ischemic heart disease.

352 views • 21 slides

Azacitidine use in post transplant relapse of MDS and AML

Azacitidine use in post transplant relapse of MDS and AML. Jennifer Vaughn, MD Bart Scott, MD. Background. Myelodysplastic syndromes Clonal hematopoetic disorder in which ineffective or dysplastic cell production leads to peripheral cytopenias

355 views • 16 slides

PharmaPoint: Asthma - Global Drug Market Forecast

Big Market Research, PharmaPoint: Global Asthma Drug Market Size, Share, Strategies, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities. Big Market Research added a new research report "PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023". Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade. The largest unmet needs mainly reflect the high level of heterogeneity of the disease, the lack of patient compliance with the standard therapies, and the high cost of medications for asthma treatment. In addition, there is a lack of diagnostic tools to provide a reliable diagnosis of asthma in young children. Annualized asthma therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2013 and forecast for ten years to 2023. More info @ http://www.bigmarketresearch.com/pharmapoint-asthma-global-drug-forecast-and-analysis-to-2023-market

350 views • 13 slides